- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Rupal Shah: The COVID-19 Pandemic Accelerated Remote Spirometry Opportunity
Rupal Shah, MD, associate professor at the University of California San Francisco, talks about how the onset of the COVID-19 pandemic created an opportunity for patients who have undergone a lung transplant to undergo spirometry testing at home instead of at the the hospital.
The onset of the COVID-19 pandemic generated an opportunity for patients who underwent a lung transplant to use spirometry testing at home instead of in the hospital, says Rupal Shah, MD, associate professor at the University of California San Francisco.
Transcript
Why did you study this topic?
For a long time in lung transplant, we have thought about how to best monitor our patients’ lung function. The way that we monitor how well the transplant is working is with spirometry, which is a test of how well your lungs can take air in and blow it out. Historically, we've had people come to the hospital every 3 months and do the tests in the lab and interpret those results. But it would be much easier if patients, especially those who live far away, could do that at home and could do it more frequently than once every 3 months. So, that was the idea behind trying to get something that we could use at home or remote monitoring.
Obviously, the onset of the pandemic really accelerated that. We were no longer allowed to have people come in for a long time, and then subsequently, everyone needed a COVID-19 test and access was much more limited. Although the concept of remote monitoring existed before the pandemic, I think the onset of the pandemic accelerated the idea of trying to rapidly implement this technology and then study how effective it is and what were the challenges to using it in our population.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
